Tang Capital Management »

Seer Cl A Ord shares owned by Tang Capital Management

Quarter-by-quarter ownership of Seer Cl A Ord (SEER) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Seer Cl A Ord

Tip: Access up to 7 years of quarterly data

All positions including Seer Cl A Ord held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seer Cl A Ord by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 674k 1.90

More positions owned by Tang Capital Management

Tarsus Pharmaceuticals (TARS)
Evolus (EOLS)
Kalvista Pharmaceuticals (KALV)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Altimmune Com New (ALT)
Immunocore Hldgs Ads (IMCR)
Inhibrx (INBX)
Eli Lilly & Co. (LLY)
Vaxcyte (PCVX)
Ptc Therapeutics I (PTCT)
Outlook Therapeutics
Rocket Pharmaceuticals (RCKT)
Immunome (IMNM)
Avadel Pharmaceuticals Sponsored Adr (AVDL)

View all positions for Tang Capital Management

Top funds holding Seer Cl A Ord

BlackRock
Softbank Group Corp
Artal Group
Vanguard Group
Acadian Asset Management
Citigroup
Geode Capital Management
Millennium Management
Kent Lake Capital
FMR
Tang Capital Management
Two Sigma Advisers
Man Group
Jacobs Levy Equity Management
Northern Trust

View all funds holding Seer Cl A Ord